The Effect of Synthesis of Pegylated Nanoliposome Containing DNAi on Reduction of BCL-2 Gene Expression in DLCL2 Cell Line
Author(s) -
Farahnaz Boozari Saravani,
Farzaneh Tafvizi,
Mahmoud Reza Jaafari
Publication year - 2018
Publication title -
qom univ med sci j
Language(s) - English
Resource type - Journals
eISSN - 2008-1375
pISSN - 1735-7799
DOI - 10.29252/qums.12.10.16
Subject(s) - reduction (mathematics) , gene , line (geometry) , cell culture , gene expression , chemistry , cell , microbiology and biotechnology , biology , biochemistry , genetics , mathematics , geometry
Methods: In this study, to prepare DNAi containing pegylated nanoliposome, 3 formulations were prepared with 5, 10, and 15% combinations of PEG 2000 with certain ratios of phospholipid and cholesterols. After purification by a Zetasizer, the mean diameter of nanoliposome was measured. Drug efficacy was determined based on the standard curve of the drug. Cytotoxicity effect of the product was determined by treatment with 0.2, 0.5, and 0.8μg/μl concentrations of each formulation in triplicate in vitro using MTT method. Then, BCL2 gene expression was analyzed in DLCL2 cell line. Data were analyzed using one way ANOVA.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom